Search


 
Results 21 - 30 of about 40 for "FDA update".

First drug approved to treat thrombocytopenia in adults with ...

Patients who received the drug for five days had increased platelet counts compared to those taking placebo.

Endoscopic spray device approved to be marketed to treat GI ...

The device delivers a mineral blend to sites of upper or lower GI bleeding and is applied during an endoscopic procedure.

Generic form of mesalamine approved | ACP ...

The drug is indicated to induce remission in adults with active, mild to moderate ulcerative colitis and to maintain remission of ulcerative colitis.

June 23, 2017 | ACP Gastroenterology Monthly

... patients with irritable bowel syndrome. FDA update. Generic form of mesalamine approved. The drug is indicated to induce ...

March 23, 2018 | ACP Gastroenterology Monthly

... mothers with chronic HBV. FDA update. FDA sends warning to duodenoscope manufacturers. The manufacturers have not ...

June 22, 2018 | ACP Gastroenterology Monthly

... hyponatremia at admission. FDA update. Drug cleared to treat moderately to severely active ulcerative colitis. It is the first ...

Proton-pump inhibitor recalled | ACP Gastroenterology ...

One lot of pantoprazole sodium for injection (40 mg per vial) was recalled in December.

January 27, 2017 | ACP Gastroenterology Monthly

... IBS after infectious enteritis. FDA update. Drug for chronic idiopathic constipation approved. The oral medication is taken ...

May 26, 2017 | ACP Gastroenterology Monthly

... and case examples. FDA update. Regorafenib now FDA-approved to treat hepatocellular carcinoma. Approved use of the ...

November 28, 2017 | ACP Gastroenterology Monthly

... stage renal disease. FDA update. Potency concerns lead to recall of anti-diarrhea drug. Recalled batches of diphenoxylate ...

Result Page: < Previous  1 2 3 4  Next >